Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Arbutus Biopharma	ABUS	22. nov 2024	3.51	+1.45
ARC Document Solutions	ARC	22. nov 2024	3.39	0.00
Arcadia Biosciences	RKDA	22. nov 2024	2.74	+5.67
Arcadium Lithium	ALTM	22. nov 2024	5.29	+0.19
ArcBest	ARCB	22. nov 2024	109.91	+0.83
Arcellx	ACLX	22. nov 2024	90.44	+3.69
Arcelor Mittal ADR	MT	22. nov 2024	25.11	-0.71
Arch Capital F Pref	ACGLO	22. nov 2024	22.90	+0.57
Arch Capital G	ACGLN	22. nov 2024	19.98	+0.05
Arch Capital Group	ACGL	22. nov 2024	99.69	+1.12
Arch Resources A	ARCH	22. nov 2024	173.64	-0.60
Archer Aviation A	ACHR	22. nov 2024	6.04	+4.50
Archer Daniels Midland	ADM	22. nov 2024	53.13	-0.11
Archrock	AROC	22. nov 2024	25.86	+0.47
Arcos Dorados	ARCO	22. nov 2024	8.40	+0.84
Arcosa	ACA	22. nov 2024	110.58	+2.07
Arcturus Therapeutics	ARCT	22. nov 2024	16.91	-0.94
Arcus Biosciences	RCUS	22. nov 2024	14.70	+2.94
Arcutis Biotherapeutics	ARQT	22. nov 2024	10.14	-0.98
Ardagh Metal Packaging	AMBP	22. nov 2024	3.73	+0.54
Ardelyx	ARDX	22. nov 2024	5.31	+3.71
Ardent Health Partners	ARDT	22. nov 2024	15.83	+0.19
Ardmore Shipping	ASC	22. nov 2024	11.85	-0.34
Ares Acquisition II	AACT	22. nov 2024	10.90	-0.09
Ares Capital	ARCC	22. nov 2024	22.02	+1.10
Ares Commercial Real Estate	ACRE	22. nov 2024	7.12	-0.56
Ares Dynamic Credit Allocation Fund	ARDC	22. nov 2024	15.27	-0.07
Ares Management A	ARES	22. nov 2024	175.52	+0.29
Ares Management Pref B	ARES-B	22. nov 2024	55.71	0.00
Argan	AGX	22. nov 2024	158.63	+2.95

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.